Biotech

All Articles

F 2G raises $100M for 2nd try to obtain brand-new antifungal to market

.After F2G's very first effort to receive a brand-new training class of antifungal to market was thw...

Moderna targets $1.1 B in R&ampD investing cuts, drops 5 systems in the middle of productivity tensions

.Moderna has actually pledged to reduce R&ampD investing by $1.1 billion by 2027. The choice to retr...

Sanofi's $80M bet on Key dystrophy medicine finishes in stage 3 go under

.Merely 4 months after Sanofi wager $80 million in upfront money on Pivot Therapeutics' losmapimod, ...

Oncternal stock drains 60% in the middle of layoffs, test terminations

.Cancer cells company Oncternal Therapeutics is actually folding all its own professional trials and...

Roche is actually supporting out chances that its injectable obesity possibility might inevitably show 25% weight loss in late-stage test

.Roche is actually keeping out hopes that its own injectable being overweight possibility could inev...

Novo Nordisk hails 'remarkable' weight reduction lead for dual-acting dental medicine in early trial

.Novo Nordisk has raised the lid on a stage 1 trial of its oral amylin and GLP-1 receptor co-agonist...

AbbVie takes legal action against BeiGene over blood stream cancer cells drug secret method

.Only a few short full weeks after winning an FDA Fast Track tag for its own investigational BTK deg...

Lilly supplies one-two blow with 2nd tranche of positive data on weekly insulin candidate

.Not long after a beneficial data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based compa...

BridgeBio reduces genetics treatment budget as scientific information let down

.BridgeBio Pharma is actually lowering its genetics treatment budget plan as well as pulling back co...

GSK gives up HSV vaccination wishes after period 2 fall short, ceding ethnicity to Moderna, BioNTech

.GSK's try to establish the 1st injection for herpes simplex infection (HSV) has ended in failure, l...